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Apoptotic cell death occurs in many tissues during embryonic
development and appears to be essential for processes including
digit formation and cardiac outflow tract remodeling. Studies in
the chick suggest a requirement for apoptosis during neurulation,
because inhibition of caspase activity was found to prevent neural
tube closure. Inmice, excessive apoptosis occurs in associationwith
failure of neural tube closure in several genetic mutants, but
whether regulated apoptosis is also necessary for neural tube
closure in mammals is unknown. Here we investigate the possible
role of apoptotic cell death during mouse neural tube closure. We
confirm the presence of apoptosis in the neural tube before and
during closure, and identify a correlation with 3 main events:
bending and fusion of the neural folds, postfusion remodeling of
the dorsal neural tube and surface ectoderm, and emigration of
neural crest cells. Both Casp3 and Apaf1 null embryos exhibit
severely reduced apoptosis, yet neurulation proceeds normally in
the forebrain and spine. In contrast, the mutant embryos fail to
complete neural tube closure in the midbrain and hindbrain.
Application of the apoptosis inhibitors z-Vad-fmk and pifithrin- to
neurulation-stage embryos in culture suppresses apoptosis but
does not prevent initiation or progression of neural tube closure
along the entire neuraxis, including the midbrain and hindbrain.
Remodeling of the surface ectoderm to cover the closed tube, as
well as delamination and migration of neural crest cells, also
appear to be normal in the apoptosis-suppressed embryos. We
conclude that apoptosis is not required for neural tube closure in
the mouse embryo.
cell death  embryo  morphogenesis  neurulation
Formation of the neural tube through the process of neuru-lation is a critical event in embryogenesis, the neural tube
being the precursor of the entire central nervous system. Neural
tube closure involves a complex sequence of morphogenetic
movements, involving elevation and bending of the neural folds,
adhesion and fusion of the apposing fold tips, and tissue remod-
eling to form a continuous neuroepithelial tube with overlying
surface ectoderm (1). Failure of closure results in neural tube
defects (NTDs), including exencephaly (in the cranial region)
and spina bifida (resulting from failure of spinal closure) (2).
The high frequency of NTDs in humans (1 per 1,000 estab-
lished pregnancies) and in more than 190 genetic mutant mice
suggests that neurulation is a sensitive and complex process.
Numerous gene functions are required for successful completion
of neural tube closure (2, 3), and different molecular pathways
are needed for various phases of the closure process. For
example, planar cell polarity signaling is required for shaping of
the neural plate and initiation of closure (2, 4), whereas bone
morphogenetic protein signaling plays an important role in
regulation of neural fold bending (5).
Although many genes have been implicated in neural tube
closure, the cellular mechanisms underlying closure are much
less well understood. One hallmark of the neurulation process is
the presence of dying cells in the neural folds during and after
closure. Cell death in the neuroepithelium was first documented
by ultrastructural studies, and dying cells were subsequently
found to exhibit the characteristic features of apoptosis (6–8).
But despite having first been noted more than 30 years ago, the
physiological role of cell death in the neuroepithelium during
mammalian neural tube closure remains to be established.
Experimental evidence of a requirement for apoptosis in
neurulation has come from findings that neural tube closure in
chick embryos fails after suppression of apoptosis by in ovo
treatment with the pan-caspase inhibitor z-VAD-fmk (9). In
mice, several knockout strains exhibit alterations in the abun-
dance of apoptotic cells during development of NTDs. Whereas
most of these strains exhibit increased cell death, a few genet-
ically determined mouse NTDs have been associated with di-
minished apoptosis (2, 3). This appears to support a requirement
for apoptosis in mouse neural tube closure, although definitive
evidence for this hypothesis is lacking. To resolve this question,
we decided to investigate experimentally the requirement for
apoptosis in mouse primary neurulation.
Results
Patterns of Cell Death During Neural Tube Closure. In mouse em-
bryos, apoptotic cells are particularly evident in the rostral
forebrain, the midline of the closed neural tube, and the rhom-
bomeres (10, 11). If regulated apoptosis were in fact required for
neurulation, then the closing neural folds should exhibit char-
acteristic patterns of apoptosis; however, this has not been
systematically investigated. We determined the spatiotemporal
distribution of apoptotic cells by whole-mount TUNEL staining
and immunostaining for activated caspase-3 at sequential stages
throughout mouse neural tube closure from embryonic day (E)
8.5 to E10. This analysis revealed that apoptosis occurs predom-
inantly in spatial and temporal correlation with 3 main events:
bending and fusion of the neural folds, postfusion remodeling of
the dorsal neural tube and surface ectoderm, and migration of
the neural crest cells (NCCs) away from the neural tube (Fig. 1).
Neural Tube Closure Is Completed in Forebrain and Spine of Mutant
Embryos Lacking Apoptosis. To investigate whether apoptosis is
required for mouse neural tube closure, we examined embryos
with targeted genetic mutations that lead to marked reduction or
absence of apoptosis. Caspases are a family of cysteine proteases
that have a primary function at several steps of the apoptotic
cascade (12). Among these proteins, caspase-3 is the major
effector caspase that cleaves protein substrates within the apo-
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ptotic cell. Casp3 mutant embryos exhibit exencephaly with
variable penetrance depending on genetic background (13). We
analyzed apoptosis in Casp3 null and wild-type embryos at E9.5
by whole-mount TUNEL staining (because immunostaining for
activated caspase-3 cannot be performed in null embryos). The
pattern of apoptosis in wild-type (C57BL/6J background) em-
bryos (Fig. 2A and B) was comparable to the CD1 embryos that
we used to establish the spatial and temporal occurrence of cell
death (Fig. 1). In contrast, Casp3/ embryos were negative for
TUNEL staining, as assessed by analysis in both whole mounts
and sections (Fig. 2C). Despite this lack of apoptosis, neurulation
proceeded to completion in both the forebrain and throughout
the spinal region of Casp3/ embryos (Fig. 2C). In contrast, the
mutant embryos exhibited failure of neural tube closure in the
caudal midbrain and throughout the hindbrain, as reported
previously (13).
We also investigated the relationship between genetic inhibi-
tion of apoptosis and neural tube closure in a second model, the
Apaf1 knockout mouse. Apaf-1, the homologue of CED-4/ARK,
is required for activation of caspase-9; lack of Apaf-1 results in
reduced activation of caspase-3 (12, 14). Immunostaining for
activated caspase-3 revealed a complete absence of apoptosis in
the open neural folds or closed neural tube at all axial levels of
Apaf1 null embryos (Fig. 2E and H), in contrast to wild-type
littermates, in which apoptotic cells were readily detected in both
closed (Fig. 2D) and closing neural tubes (Fig. 2G). Occasional
positive cells were observed in Apaf1/ embryos, but only in
such tissues as dorsal root ganglia, where apoptosis is especially
abundant (Fig. 2H). As reported previously (14), Apaf1/
embryos exhibited midbrain and hindbrain exencephaly (data
not shown), whereas the forebrain and spinal regions exhibited
normal neural tube closure.
Thus, the analysis of Casp3 and Apaf1mutants demonstrates
that, contrary to expectations based on previous chick studies
(9), apoptosis is not required for neural tube closure either at
the rostral-most (forebrain) level or throughout the spinal
region. In contrast, because both mutants exhibit failure of
closure in the midbrain and hindbrain, the possibility remains
that apoptosis is specifically required for closure at this level
of the neuraxis.
Inhibition of Apoptosis In Vitro Does Not Perturb Neural Tube Closure.
To complement the genetic approach to analysis of apoptosis in
mouse neurulation, we next used the whole embryo culture
system (15) to treat neurulation-stage embryos with chemical
inhibitors of apoptosis. The pan-caspase inhibitor z-VAD-fmk
and the p53 inhibitor pifithrin- are both known to suppress
apoptosis in various systems (16). First, we evaluated the efficacy
and duration of action of the inhibitors by culturing embryos for
increasing periods and then assessing the suppression of apo-
ptosis by whole-mount TUNEL staining and immunostaining for
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Fig. 1. Spatiotemporal analysis of apoptosis in the neuroepithelium.
TUNEL (A–C) and activated caspase-3 (D–F) staining of CD1 embryos at E8.5
(A and D), E9.0 (B and E), and E9.5 (C and F) reveals the presence of
apoptotic cells at several sites in the open neural folds and closed neural
tube. Scattered TUNEL-positive (blue) cells are seen throughout the neural
folds (A and B) and are particularly abundant in the forebrain neural folds
(arrow in A), in a rhombomeric pattern within the hindbrain (arrowheads
in A and B), and in the dorsal midline of the closed neural tube (black
arrows in B and C). The locations of cells positive for activated caspase-3
(brown staining, arrowheads in D–F) correspond to sites of abundant
TUNEL staining. Representative sections in D–F are from levels indicated by
dotted lines in A–C, respectively. Drawings (G–I) summarize the main sites
of apoptosis (in red) seen at E8.5 (G), E9.0 (H), and E9.5 (I). At least 8
embryos per stage were analyzed. (Scale bar: 0.1 mm.)
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Fig. 2. Genetic inhibition of apoptosis does not prevent neurulation in
forebrain or spine. (A–C) Whole-mount TUNEL staining of Casp3wild-type (A
andB) andnull (C) embryos. Insets show transverse sections through the spinal
region at levels indicated by dashed lines inA–C. Despite exposure to identical
staining conditions, there is a complete lack of TUNEL-positive cells in mutant
embryos (C), whereas wild-type littermates exhibit plentiful apoptosis (white
arrowheads inA and B), in a pattern comparable to that seen in CD1 embryos
(see Fig. 1). Note that the neural tube has closed in the forebrain and spinal
region of the Casp3/ embryo, whereas the caudal midbrain and hindbrain
have remained open (i.e., exencephaly, between the yellow arrows). (D–I)
Transverse sections through the spinal neural tube (at axial levels shown in F
and I) ofApaf1wild-type (D andG) andnull (E andH) embryos immunostained
for activated caspase-3. In themutant embryos, no staining is evident in either
closed (E) or open (H) neural tube, whereas wild-type littermates exhibit
immunoreactive cells in the neuroepithelium at both closed (D) and open (G)
neural tube levels. The Apaf1/ embryos exhibit midbrain/hindbrain exen-
cephaly similar to that of the Casp3/ embryos, whereas the neural tube is
closed in forebrain and spinal regions (not shown). (Scale bars: 0.1 mm.)
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activated caspase-3. Apoptosis was completely suppressed by
z-VAD-fmk and significantly suppressed by pifithrin- during a
4-h (Fig. 3A–D and G) or 8-h (Fig. 3E–G) culture period. These
effects were observed at doses that had no embryotoxic or
growth-retarding effects, as indicated by yolk sac circulation,
growth parameters, and morphological appearance (Fig. 3A–F;
data not shown). Embryos also were cultured overnight for 16 h
in the presence of inhibitors to assess whether apoptosis would
recover over time. Immunostaining for activated caspase-3 re-
vealed a significant (70%) reduction in the abundance of
apoptotic cells in embryos exposed for 16 h to z-VAD-fmk or
pifithrin- compared with controls (Fig. 3G).
Closure of the neural tube in the mouse is a discontinuous
process with initiation sites at the cervical–hindbrain boundary
(closure 1), the forebrain–midbrain boundary (closure 2), and
the rostral forebrain (closure 3) (1). Progression of closure
between these sites results in formation of the neural tube in the
cranial region, whereas the spinal neural tube is formed by
caudal progression of closure from the site of closure 1, with final
closure at the posterior neuropore. To analyze the effects of lack
of apoptosis on each of these events, embryo culture was
initiated at developmental stages preceding closure at particular
sites (Fig. 3H; Table 1). Thus, closure 1 is completed after6–7
h in embryos cultured from the 1–3 somite stage. Whereas
exposure to either z-VAD-fmk or pifithrin- during this culture
period completely blocked apoptosis (Fig. 3E–G), it had no
detrimental effect on closure 1 (Table 1). Embryos cultured
from the 9–11 somite stage underwent initiation of closure at
sites 2 and 3 after 6–7 h, followed by progression to final
formation of the cranial neural tube by the 15–16 somite stage
(8–10 h into the culture period). The inhibitors had no apparent
deleterious effect on completion of any of these cranial neuru-
lation events, with 100% closed brains found in all groups (Table
1). These experiments suggest that apoptosis is dispensable for
closure of the entire cranial neural tube, including the midbrain
and hindbrain, which remained open in the Casp3 and Apaf1
mutants.
Spinal neurulation also appears independent of apoptosis. The
length and width of the posterior neuropore after culture were
not significantly greater in the treated embryos than controls
(Fig. 4A and B). Moreover, these values decreased progressively
with somite stage, as expected (17).We tested whether inhibition
of apoptosis may be compensated for by decreased proliferation
in the spinal neural folds, resulting in an overall balance of cell
number. The mitotic index, as assessed by immunostaining for
phospho-histone H3, did not differ significantly between the
treatment groups (Fig. 4C–F). There appeared to be no com-
pensatory reduction in proliferation in the inhibitor-treated
embryos.
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Fig. 3. Pifithrin- and z-VAD-fmk suppress apoptosis in cultured embryos.
(A–F) TUNEL staining of DMSO-treated control (A, C, and E), pifithrin-–
treated (B), and z-VAD-fmk–treated (Dand F) E8.5 embryos after 4h (A–D) and
8 h (E and F) of culture. TUNEL-positive cells are clearly visible in the control
embryos (e.g., arrowhead in C) but are absent from the treated embryos. (G)
After 6hof culture, there arenoactivated caspase-3–positive cells in the spinal
neural tube immediately rostral to the site of closure in the z-VAD-fmk–
treated embryos, whereas the number of apoptotic cells is significantly re-
duced in embryos treated with pifithrin- (dark-gray bar) compared with
controls (black bar). After 16 h of culture, the number of activated caspase-
3–positive cells in the spinal neural tube rostral to the site of closure remains
significantly diminished in embryos treated with z-VAD-fmk (light-gray bar)
and pifithrin- (dark-gray bar) compared with controls (black bar) (*P  .05;
1-way ANOVAwith Dunn’s correction). Ten sections were counted from each
of 2 embryos in each experimental group. (H) Time line of embryo cultures in
the study. Numbers indicate somite stages, and yellow lines (divided into
hourly intervals) indicate the duration of cultures designed to evaluate the
effect of inhibition of apoptosis on neurulation. Red portions of the lines
indicate the stage at which particular events of neural tube closure occur.
Thus, closure initiation (closure 1) and the events of cranial neurulation
(closures 2 and 3) occurred 6–7 h into each culture period, when apoptosis
inhibition was maximal. Neural fold remodeling and posterior neuropore
closure were assessed 12–16 h into the second culture period, when apo-
ptosis was significantly inhibited but not maximal.
Table 1. Initiation and completion of cranial neural tube closure in cultured embryos does not
require apoptosis
Experimental
group
Somite number at the
start of culture
Somite number at the end
of culture ( SEM)
Embryos with
complete closure
Assessment of closure 1
Control 1–3 10.42  0.65 7/7 (100%)
Pifithrin- 1–3 10.71  0.29 7/7 (100%)
z-VAD-fmk 1–3 8.57  0.37 7/7 (100%)
Assessment of closures 2 and 3 and completion of cranial neurulation
Control 9–11 20.50  0.59 16/16 (100%)
Pifithrin- 9–11 20.25  0.86 9/9 (100%)
z-VAD-fmk 9–11 19.56  0.52 16/16 (100%)
Embryos were cultured in the presence of DMSO (vehicle control) or apoptosis inhibitors through to the time
of initiation of neurulation (closure 1) or the occurrence of cranial neurulation (closures 2 and 3). The culture
periods are illustrated in Fig. 3H. The number of somites at the end of the culture period was slightly lower in the
z-VAD-fmk–treated embryos than in controls, although there was no statistically significant difference between
treatment groups at either stage (P .05; 1-way ANOVA).
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Postfusion Remodeling and NCC Migration Do Not Depend on Apo-
ptosis. Although our data suggest that apoptosis is not required
for adhesion and fusion of the neural folds, we hypothesized that
it may play a role in the tissue remodeling process that results in
separation of the newly formed neural tube from the overlying
surface ectoderm. To investigate this idea, embryos were cul-
tured overnight in the presence of z-VAD-fmk or pifithrin-, and
inhibition of apoptosis was confirmed by immunostaining for
activated caspase-3 (Fig. 5A–C). Somite matched embryos were
sectioned and immunostained for the surface ectoderm marker
E-cadherin. Analysis of the site of neural tube closure and the
immediately rostral sections, where remodeling occurs, revealed
no difference in tissue architecture between the control and
treated embryos (Fig. 5D–I). Specifically, the midline surface
ectoderm was complete in all embryos, despite almost total
inhibition of apoptosis. These observations argue against the
idea that apoptosis is required for the tissue remodeling neces-
sary to separate the surface ectoderm from dorsal neural tube.
Because TUNEL-positive cells are abundant at sites of NCC
migration, we tested whether cell death is required for NCC
migration from the tips of the neural folds. After overnight
culture of embryos with apoptosis inhibitors, we performed
whole-mount in situ hybridization for the NCC marker cad-
herin-6. In embryos cultured under control conditions, cad-
herin-6 was expressed in distinct streams of NCC migrating from
the hindbrain toward the first and second branchial arches (Fig.
6A). Comparable expression patterns were observed in embryos
cultured in the presence of pifithrin- or z-VAD-fmk (Fig. 6B
and C), and the NCC streams remained distinct. Thus, based on
this evidence, apoptosis apparently is not required for normal
NCC emigration from the hindbrain in mice.
Discussion
In the present study, we observed apoptotic cells in specific
locations within the closing neural tube, as described previously
(6–8). This supports the hypothesis that apoptosis may have a
functional role in neural tube closure, as suggested for chick
neurulation (9). Indeed, several targeted mutant mouse strains
exhibit both NTDs and altered apoptosis levels (2, 3). For
example, NTDs in embryos lackingApoB (18), Bcl10 (19),Mdm4
(20), or Tulp3 (21) function are all associated with increased
rates of apoptosis. In these cases, excess apoptosis could result
in insufficient numbers of cells to participate in the crucial
morphogenetic movements underlying neural tube closure.
In other genetic mutants [e.g., Trp-53 (22), Casp3 (23), and
Apaf1 (14) knockouts], NTDs are associated with reduced levels
of embryonic apoptosis. We examined this category of mutants
in greater detail and found that whereas apoptosis is entirely
suppressed in the closing neural tube of both Casp3 and Apaf1
null mutants, closure occurs normally in the forebrain and spinal
regions. Only in the midbrain and hindbrain of these mutants is
closure defective, leading to exencephaly. Strikingly, however,
when we cultured neurulation-stage mouse embryos in the
presence of chemical inhibitors of apoptosis, we found that even
the midbrain and hindbrain close normally in the absence of cell
death. Similarly, remodeling of the neuroepithelium and surface
ectoderm postfusion proceeded normally. Thus, our findings
argue strongly that the reduced apoptosis in theCasp3 and Apaf1
mutant mice is unlikely the direct cause of their cranial NTDs,
and that other cellular functions likely are disturbed, leading to
failure of neurulation.
One difference between genetic and inhibitor-based suppres-
sion of apoptosis is the period of developmental time over which
apoptosis is absent. In the case of the Casp3 and Apaf1 mutants,
A B
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Fig. 4. Inhibition of apoptosis does not adversely affect spinal neurulation. After overnight culture in the presence of apoptosis inhibitors, dimensions of the
posterior neuropore indicate the progression of spinal neurulation. No differences in posterior neuropore length (A) or width (B) were noted between the
experimental groups at each somite stage analyzed. Note the progressive decline in both parameters with increasing somite stage. A minimum of 3 embryos
per experimental group were assessed at each somite stage. Compared with control embryos (C), culture in the presence of pifithrin- (D) or z-VAD-fmk (E) had
no apparent effect on mitotic activity, as indicated by immunostaining for phospho-histone H3 (pink-stained cells in C–E). (F) Mitotic index, calculated for the
5 sections rostral to the site of neural tube closure (3 embryos per experimental group), did not differ between treatment groups (P.05; 1-way ANOVA). Graph
bars represent mean  SE.
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long-term suppression of apoptosis could lead to alterations in
the number or distribution of cells in the neural tube, which
might be incompatible with closure in the midbrain and hind-
brain, although permissive for closure in the forebrain and spine.
In contrast, short-term suppression of apoptosis in embryo
culture clearly demonstrates that the entire sequence of neural
tube closure events can occur in the absence of cell death.
In terms of the overall role of apoptosis in differing develop-
ment contexts, a requirement for cell death in removal of tissue
[as in, e.g., digit separation (24)] is mechanistically easy to
explain, and a role in large-scale remodeling (as in, e.g., the
cardiac outflow tract) also is plausible (25). A role in tissue
fusion is less well defined, however. We find it intriguing that the
requirement for apoptosis in another mammalian fusion process,
palatal closure, also is controversial. Cell death is abundant in
the midline epithelial seam before mesenchymal confluence
during fusion of the palatal shelves; however, experimental
inhibition of apoptosis during palatal shelf fusion has produced
conflicting results, with reports of prevention (26) or no detri-
mental effect (27) on palatal fusion. Thus, the occurrence of
apoptosis at the site of tissue fusion events during development
may not indicate a functional role, but rather may be a secondary
outcome.
Why do our findings differ from those based on inhibition of
apoptosis in chick neurulation (9)? Avian and mammalian
neurulation have some fundamental differences (28), raising the
question of whether apoptosis may play an obligatory role in
neural tube closure in chicks but not in mice. When chick
embryos were treated with z-Vad-fmk, the finding of failed
neural tube closure was tentatively related to defective remod-
eling of the neuroepithelium and surface ectoderm (9). For this
reason, we specifically assessed tissue remodeling after neural
fold fusion in our mouse embryos, but observed no defect in this
process in the absence of apoptosis. Interestingly, data from a
recent study of chick neurulation (29) show that both neural tube
closure and tissue remodeling can occur normally after treat-
ment with z-Vad-fmk. Thus, whether there is actually a funda-
mental difference between the requirement for apoptosis in
avian and mammalian neurulation or whether cell death is
dispensable for neural tube closure in both animal groups
remains unclear.
In conclusion, we confirm the association of extensive apo-
ptosis with the closing neural tube in mouse embryos, but
demonstrate experimentally that this cell death is not essential
for completion of neural tube closure.
Experimental Procedures
Mice. The animal studies were carried out under regulations of the UK’s
Animals (Scientific Procedures) Act 1986 and in accordance with guidance
issued by theMedical Research Council in Responsibility in the Use of Animals
for Medical Research (http://www.mrc.ac.uk/Utilities/Documentrecord/
index.htm?dMRC001897). Random-bred CD1 mice were purchased from
Charles River Laboratories. Mice were paired overnight, and females were
checked for copulation plugs the next morning, designated day E0.5. Null
mutant embryos for Casp3 and Apaf1 and corresponding wild-type embryos
(n  3 for each genotype) were obtained and genotyped as reported previ-
ously (13, 30).
Whole Embryo Culture. Embryos were explanted and cultured in rat serum as
describedpreviously (15). Yolk sac circulation, crown-rump length, and somite
number provided measures of viability, growth, and developmental progres-
sion, respectively (31). Stock solutions of z-VAD-fmk (Sigma-Aldrich) in DMSO
and pifithrin- (Calbiochem) in PBS were added to cultures as 0.1% (vol/vol)
additions to obtain the final concentrations of 200 M and 500 M, respec-
tively. Initial experiments demonstrated that these doses were not embryo-
toxic at this developmental stage. An equivalent volume of DMSOwas added
to control cultures, because no difference between PBS and DMSO (at 0.1%)
was observed in initial experiments. Embryos were randomly allocated to
treatment groups to minimize the effect of litter-to-litter variation. Embryos
were rinsed in PBS and fixed in 4%paraformaldehyde for immunohistochem-
istry, in situ hybridization, or TUNEL analysis.
A B C
D E F
G H I
Fig. 5. Apoptosis is not required for neural fold remodeling postfusion.
Transverse sections through the spinal neural tube of stage-matched (19
somites) control (A, D, and G), pifithrin-–treated (B, E, and H), and z-VAD-
fmk–treated (C, F, and I) embryos, immunostained for activated caspase-3
(A–C) or E-cadherin (D–I). Note the lack of apoptosis in the inhibitor-treated
embryos (B and C) 12 h into the culture period compared with the control
embryos, inwhich caspase-3–positive cells are seen both in themidline (arrow
in A) and elsewhere. At an axial level immediately rostral to the site of neural
fold fusion, the E-cadherin–positive surface ectoderm (arrowhead in E) is
already intact in all treatment groups (D–F), indicating completion of neural
fold remodeling. Themidline dorsal indentation indicates the close proximity
of the section to the point of neural fold remodeling. The surface ectoderm
also is intact at a more rostral level, where remodeling occurred earlier (G–I).
Breaks in the surface ectoderm lateral to the neural tube represent histolog-
ical processing artifacts. Abbreviations: g, hindgut; n, neural tube. (Scale bar:
0.1 mm.)
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Fig. 6. Neural crest migration from the hindbrain does not appear to be
affected by inhibition of apoptosis.Whole-mount in situ hybridization for the
neural crest marker cadherin-6 in control (A), pifithrin-–treated (B), and
z-VAD-fmk–treated (C) embryos reveals no differences in the pattern of NCC
emigration. (D–F) High-magnification views of the white boxed areas shown
in A–C. Two distinct streams of NCC (I and II; arrows in A) are seen to migrate
toward thefirst and second branchial arches. In the inhibitor-treated embryos
(B, C, E, and F), the separation ofmigration streams is retained, and there is no
obvious reduction in NCC number. Aminimumof 3 embryos per experimental
group were analyzed. Because z-VAD-fmk treatment causes slight growth
retardation, some embryos were cultured for an additional 4 h, to allow
comparisonwith stage-matched controls (inset inC, with concurrently hybrid-
ized control shown in the inset in A). (Scale bar: 0.2 mm.)
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Immunohistochemistry. Embryos were embedded in paraffin wax, and 7-m
transverse sections were processed for immunostaining using antibodies spe-
cific for phospho-histone H3 (Upstate Biotechnology), activated caspase-3
(Cell Signaling Technology), and E-cadherin (Cell Signaling Technology). Sec-
tions were counterstained with methyl green. The numbers of positive cells
were counted as described previously (32, 33).
Whole-Mount In Situ Hybridization. A digoxygenin-labeled cRNA probe for
Cadherin-6 was used as described previously (34).
TUNEL of Whole Embryos. Embryos were fixed in 4% paraformaldehyde, and
whole-mount TUNEL was performed as described previously (35).
Statistical Analysis. Statistical tests were performed using SigmaStat version
3.5 (Systat Software).
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